The global robotic biopsy devices market size reached a valuation of US$ 440.2 million in 2023 and is expected to grow at a CAGR of 9.3% over the forecast period. Robotic biopsy systems are leading the global market and held a share of about 59.8% in 2023. The market is expected to reach a valuation of around US$ 1,072.3 million by the end of 2033.
Drivers in the Robotic Biopsy Devices Industry
Challenges for Companies in the Robotic Biopsy Devices Industry
Investment Opportunities in the Robotic Biopsy Devices Industry
Latest Trends in the Robotic Biopsy Devices Industry
| Attributes | Key Statistics |
|---|---|
| Global Robotic Biopsy Devices Market Estimated Size (2023) | US$ 440.2 million |
| Projected Market Valuation (2033) | US$ 1,072.3 million |
| Value-based CAGR 2023 to 2033 | 9.3% |
| Collective Value Share: Top 5 Countries | 50.5% |
The goal of a biopsy process is to confirm a cancer diagnosis by removing a tissue sample from a suspected lesion for a thorough pathological analysis. Traditional biopsy techniques rely on the radiologist manually inserting the needle. However, robotic systems add more stiffness and precision using a stable robotic manipulator than human hands.
They help the needle to retract more precisely while still preserving the tissue sample. Imaging methods, including computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and other technologies, are used to locate lesions before the intervention. These are also used to guide the needle during the process by utilizing image feedback.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The robotic biopsy devices industry witnessed a steady CAGR of 5.8% from 2018 to 2022.
Prostate cancer is the second-most prevalent cancer and affects men, while breast cancer is one of the most common malignancies and the primary cause of cancer death among women. For high-risk patients to receive the best possible care or to prevent overtreatment in low-risk individuals, early and accurate identification of breast and prostate cancer is crucial.
Needle biopsy is the most reliable method for detecting breast and prostate cancer, as well as for determining how serious the stage of cancer is. Breast and prostate biopsies have a few similarities. They can be done with MRI or ultrasound guidance, and several core specimens are collected occasionally by using sample planning.
Although it is the simplest and fastest method, ultrasound navigation is not always accurate. Both MRIs and stereotactic biopsies are expensive and time-consuming procedures.
Using a robotic system for performing biopsies has the advantages of greater accuracy & precision, stability, superior hand-eye coordination, and lesser insertions. A robot could also improve the way humans analyze 3D pre-operative data as it does not develop fatigue or musculoskeletal conditions from carrying out the same task repeatedly for prolonged periods. These benefits will make surgeries quicker, less expensive, and less traumatic for the patient.
Additionally, advancements in healthcare infrastructure & institutional settings and the emergence of novel devices for minimally invasive interventions are expected to promote the adoption of robotic biopsy devices worldwide.
Owing to the aforementioned factors, the global robotic biopsy devices industry is expected to grow at a CAGR of 9.3% during the forecast period from 2023 to 2033.
Image-guided surgery extensively makes use of surgical robots to simplify and improve device and instrument positioning. Any surgery requiring extreme precision benefits from robotic surgical tool placement systems.
By ensuring that surgical instruments are introduced at proper angles and depths, these technologies can streamline operating room procedures. Involuntary tremors frequently prevent individuals from achieving the level of precision required during surgical procedures.
Robotic positioning of surgical equipment has been proven to be effective in orthopedic and neurosurgical procedures. It is currently being investigated as a way to enhance the results of laser therapy, tumor resection, and biopsy procedures.
Thus, advancements in robot-guided instrument positioning will aid growth in the global robotic biopsy devices industry over the forecast period.
Principal Consultant
Robotic biopsy devices are highly advanced in terms of technology and can cater to image-guided minimally invasive procedures. But, the cost of equipment and set-up of such systems is higher than conventional healthcare equipment. Therefore, in emerging economies, extensive cost constraints may prevent product adoption among local healthcare institutions.
Moreover, for extensive pre-operative planning, there is a requirement for skilled professionals to interpret image-guided biopsy navigation. This proposes an additional capital expense for institutional settings, which may hamper growth.
Rapid Development of the Healthcare Sector in the United States to Drive Demand for Punch Biopsy Devices
The United States currently dominates the North America robotic biopsy devices industry, and it generated a share of about 34.0% in 2023. The country presents an extensive history of patenting for medical devices and is thus leading the robotic biopsy devices industry. The presence of a developed healthcare infrastructure and easy accessibility to advanced healthcare services among the general population would further support the country’s growth.
Key Players in the United Kingdom to Develop Novel Bone Marrow Biopsy Needles
The United Kingdom is set to hold a share of nearly 5.2% in the global robotic biopsy devices industry during the forecast period. The country marks the presence of several innovative market players, such as Medtronic, for robotic medical devices.
With the presence of various established key players in the country, the market for robotic biopsy devices in the United Kingdom is set to gain traction. Moreover, growing CE approvals for robotic biopsy devices will propel the industry.
Rising Prevalence of Lung Cancer in China to Aid Demand for Biopsy Forceps
China held around 5.2% of the share of the global market in 2023. In China, lung cancer is the most prevalent malignant tumor in terms of the number of new cases and the number of fatalities. To increase the survival rate of lung cancer patients, early detection and treatment are essential.
As chest CT examinations are becoming more widespread, new lung nodules are being identified. But, the final diagnosis ultimately requires verification by the gold standard test or pathological investigation. Therefore, a novel way of safe, precise, whole-lung diagnosis and therapy is urgently required in medical practice.
In March 2022, for instance, China completed the first domestic robotic-assisted trans-bronchial lung nodule biopsy. Similar developments are expected to boost growth in the China robotic biopsy devices industry.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Demand for Minimally Invasive Surgeries to Boost Sales of Automatic Biopsy Needle Systems
Robotic biopsy systems are expected to showcase high growth at a CAGR of 10.4% by the end of 2033. The segment held a share of around 59.8% in the global market in 2023, finds FMI. The growing installation of minimally invasive surgical robots around the globe has propelled sales of robotic biopsy systems.
Healthcare Professionals to Adopt Innovative Brain Biopsy Instruments
Brain biopsy held a revenue share of around 34.8% in 2023, and the segment is expected to display lucrative growth over the forecast period at a CAGR of about 12.3%. The emergence of novel medical devices owing to ongoing developments in the field of minimally invasive neurosurgery is set to aid growth. These developments would also lead to greater advancements in the assessment of cancer and disease progression.
Hospitals to Opt for Prostate Biopsy Devices to Provide Better Care
Hospitals held the highest market share of around 57.5% in 2023. With the growing prevalence of several types of cancer and the establishment of novel healthcare infrastructures, the hospital segment holds a considerable market value share among the other end users.
The global robotic biopsy devices industry is highly competitive, with the presence of a large number of key players. The majority of market participants are focusing on diversifying their product portfolios and introducing novel devices with innovative features at relatively low costs to attract a large consumer base.
Some of the recent industry developments are:
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | US$ 440.2 million |
| Projected Market Valuation (2033) | US$ 1,072.3 million |
| Value-based CAGR (2023 to 2033) | 9.3% |
| Historical Data Available for | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Market Analysis | Value (US$ million) |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, and South Africa |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Medtronic; Renishaw plc; iSYS Medizintechnik GmbH; Mazor Robotics; Biobot Surgical Pte Ltd; Medrobotics; Medtech SA |
| Report Coverage | Market forecast, brand share analysis, competition intelligence, DROT analysis, market dynamics and challenges, strategic growth initiatives |
The market is estimated to secure a valuation of US$ 440.2 million in 2023.
The growth potential of the robotic biopsy devices market is 9.3% through 2033.
High cost of the research and development is likely to limit the market growth.
Rising emphasis on early detection and technological advancements are expected to drive sales of robotic biopsy devices.
Collaboration with research organizations and healthcare institutions may provide growth prospects for the market players.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Systems
5.3.2. Instrument & Accessories
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Brain Biopsy
6.3.2. Lung Biopsy
6.3.3. Prostate biopsy
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Academic & Research Institutes
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Application
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Application
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Application
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Application
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Application
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Application
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Application
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Application
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Application
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Application
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Application
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product
16.22.2.2. By Application
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product
16.23.2.2. By Application
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Medtronic
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Renishaw plc
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. iSYS Medizintechnik GmbH
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Mazor Robotics
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Biobot Surgical Pte Ltd
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Medrobotics
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Medtech SA
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Accuray Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Auris Health, Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Hologic, Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Robotic Biopsy Devices Market
